First, we analyzed the relationships between pCR and clinicopathologic characteristics and found that the rate of pCR was associated with tumor size, histologic grade, HER2 status, TNM stage, immunotype in the testing cohort and the validation cohort (all p < 0.05) (Table 2). Here, ERBB2 is linked to neoplasm.